We are live on ! Find out more
CLGN icon

CollPlant Biotechnologies
CLGN

15 hedge funds and large institutions have $3.33M invested in CollPlant Biotechnologies in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

15% more funds holding

Funds holding: 13 → 15 (+2)

0.02% more ownership

Funds ownership: 1.11% → 1.13% (+0.02%)

27% less capital invested

Capital invested by funds: $4.59M → $3.33M (-$1.25M)

Holders
15
Holders Change
+2
Holders Change %
+15.38%
% of All Funds
0.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WPC
Waters Parkerson & Co
Louisiana
+$46.7K
2
AE
AMH Equity
New York
+$30K
3
Wells Fargo
Wells Fargo
California
+$10.6K
4
UBS Group
UBS Group
Switzerland
+$6.55K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$1.76K

Top Sellers

Rank Fund Capital Flow
1
Brown Advisory
Brown Advisory
Maryland
-$29.1K
2
PA
Pinnacle Associates
New York
-$1.76K
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.06K

CLGN Hedge Fund Activity: Q1 2025 in Review

15 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q1 2025, worth a combined $3.33M — down 27% from $4.59M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new CLGN positions and 0 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Waters Parkerson & Co, opening a new position worth an estimated $46.7K. The largest seller was Brown Advisory, cutting an estimated $29.1K.

  • 15 institutional investors held CollPlant Biotechnologies (CLGN) as of Q1 2025, up from 13 in Q4 2024.
  • Funds reported $3.33M of CollPlant Biotechnologies stock for Q1 2025, down 27% quarter-over-quarter.
  • 2 funds opened new CollPlant Biotechnologies positions in Q1 2025 and 0 closed out, a net change of +2 holders.
  • The largest CollPlant Biotechnologies buyer in Q1 2025 was Waters Parkerson & Co, an estimated $46.7K added.
  • The largest CollPlant Biotechnologies seller in Q1 2025 was Brown Advisory, an estimated $29.1K sold.

Based on aggregated 13F filings for Q1 2025.